Drug Trial Radar · NCT07476326
Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Last checked: Nov 20, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Sep 9, 2026
Primary completion
Aug 16, 2027
Study completion Feb 16, 2028
Sponsor
- Lead sponsor
- Biocon Biologics UK PLCIndustry
- Sponsor type
- Industry
- First posted
- Mar 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the pharmacokinetics (PK) similarity of Bmab1700 (an intended nivolumab biosimilar), compared with United States (US)-licensed Opdivo, in participants after complete surgical removal of melanoma.
Conditions
- Melanoma
Interventions
Bmab1700Drug
Intravenous infusion.
OpdivoDrug
Intravenous infusion.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Concentration-Time Curve from Time 0 (Day 1) To Day 29 After the First Dose (AUC0-28days) of Bmab 1700 and OpdivoTime frame: Week 0 through Week 4
- Area Under the Concentration-Time Curve Over a Dosing Interval (AUC0-tau) of Bmab 1700 and OpdivoTime frame: Week 16 through Week 20
Locations
46 sites in 10 countries. Site status is shown where the registry gives one.
Biocon Investigational Site
Bento Gonçalves, Brazil · Not yet recruiting
Biocon Investigational Site
Ijuí, Brazil · Not yet recruiting
Biocon Investigational Site
Pará, Brazil · Not yet recruiting
Biocon Investigational Site
Porto Alegre, Brazil · Not yet recruiting
Biocon Investigational Site
Rio de Janeiro, Brazil · Not yet recruiting
Biocon Investigational Site 1
Santa Catarina, Brazil · Not yet recruiting
Biocon Investigational Site 2
Santa Catarina, Brazil · Not yet recruiting
Biocon Investigational Site
Santa Catarina, Brazil · Not yet recruiting
Biocon Investigational Site 1
São Paulo, Brazil · Not yet recruiting
Biocon Investigational Site 2
São Paulo, Brazil · Not yet recruiting
Biocon Investigational Site
São Paulo, Brazil · Not yet recruiting
Biocon Investigational Site
Providencia, Chile · Not yet recruiting
Biocon Investigational Site
Recoleta, Chile · Not yet recruiting
Biocon Investigational Site 1
Santiago, Chile · Not yet recruiting
Biocon Investigational Site
Santiago, Chile · Not yet recruiting
Biocon Investigational Site
Batumi, Georgia · Not yet recruiting
Biocon Investigational Site
Kutaisi, Georgia · Not yet recruiting
Biocon Investigational Site 1
Tbilisi, Georgia · Not yet recruiting
Biocon Investigational Site 3
Tbilisi, Georgia · Not yet recruiting
Biocon Investigational Site 4
Tbilisi, Georgia · Not yet recruiting
Biocon Investigational Site 5
Tbilisi, Georgia · Not yet recruiting
Biocon Investigational Site
Tbilisi, Georgia · Not yet recruiting
Biocon Investigational Site
Chisinau, Moldova · Not yet recruiting
Biocon Investigational Site
Bucharest, Romania · Not yet recruiting
Biocon Investigational Site
Cluj-Napoca, Romania · Not yet recruiting
Biocon Investigational Site
Craiova, Romania · Recruiting
Biocon Investigational Site 1
Belgrade, Serbia · Recruiting
Biocon Investigational Site
Belgrade, Serbia · Recruiting
Biocon Investigational Site
Kamenitz, Serbia · Recruiting
Biocon Investigational Site
Kragujevac, Serbia · Recruiting
Biocon Investigational Site
Niš, Serbia · Recruiting
Biocon Investigational Site
George, South Africa · Not yet recruiting
Biocon Investigational Site 1
Johannesburg, South Africa · Not yet recruiting
Biocon Investigational Site
Johannesburg, South Africa · Not yet recruiting
Biocon Investigational Site 1
Barcelona, Spain · Not yet recruiting
Biocon Investigational Site
Barcelona, Spain · Not yet recruiting
Biocon Investigational Site
Madrid, Spain · Not yet recruiting
Biocon Investigational Site
Murcia, Spain · Not yet recruiting
Biocon Investigational Site
Sabadell, Spain · Not yet recruiting
Biocon Investigational Site 1
Seville, Spain · Not yet recruiting
Showing 40 of 46 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.